UK, EU regulators confirm safety of AstraZeneca’s Covid-19 vaccine
MHRA concluded that there is no evidence that blood clots in veins are occurring more than expected in…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
19 Mar 21
MHRA concluded that there is no evidence that blood clots in veins are occurring more than expected in…
15 Mar 21
Earlier, the Republic of Ireland took a similar decision over reports of blood clotting in adults in Norway
12 Mar 21
EC authorised the vaccine to prevent the Covid-19 in people aged 18 years and older, in all 27…
08 Mar 21
The company claimed that its Yescarta is the first chimeric antigen receptor (CAR) T-cell therapy approved for patients…
04 Mar 21
The expanded approval is based on CROWN trial, which showed that treatment using Lorbrena reduced the risk of…
01 Mar 21
The Covid-19 vaccine has been granted emergency use authorisation after evaluation of safety, effectiveness and manufacturing quality by…
25 Feb 21
AbbVie claims that HUMIRA is the first and only subcutaneous biologic treatment for active ulcerative colitis in paediatric…
17 Feb 21
Entresto benefits patients with both heart failure with reduced ejection fraction (HFrEF) and heart failure with preserved ejection…
16 Feb 21
Plavix is an antiplatelet medication or blood thinner, intended to reduce the risk of heart disease and stroke…
15 Feb 21
Panzyga was previously approved in the US to treat primary humoral immunodeficiency in people aged two years and…